Diagnostic performance of prostate cancer antigen 3 and the Prostate Health Index in detecting overall and clinically significant prostate cancer in men at first biopsy: A meta-analysis

被引:5
作者
Jia, Wei [1 ]
Wu, Bo [1 ,2 ]
Shao, Yuan [1 ]
Cao, Xiaoming [2 ]
Wang, Dongwen [1 ,3 ,4 ]
机构
[1] Shanxi Med Univ, Taiyuan, Shanxi, Peoples R China
[2] Shanxi Med Univ, Dept Urol, Hosp 1, Taiyuan, Shanxi, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Shenzhen 518116, Guangdong, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Shenzhen Hosp, Shenzhen 518116, Guangdong, Peoples R China
关键词
clinically significant prostate cancer; meta‐ analysis; prostate cancer; prostate cancer antigen 3; Prostate Health Index; URINARY PCA3; INITIAL BIOPSY; SERUM ISOFORM; ASIAN MEN; PSA; PERCENT-P2PSA; ACCURACY; PREDICT; P2PSA; PHI;
D O I
10.1111/iju.14464
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To evaluate the diagnostic value of prostate cancer antigen 3 and the Prostate Health Index for the detection of overall and clinically significant prostate cancer at initial biopsy. Methods A search was conducted in the online databases PubMed, Embase and the Cochrane database, and relevant articles published up to 23 February 2020 were extracted. Results Twenty studies including 10 376 patients were included in the meta-analysis. The pooled sensitivity and specificity were 0.55 (95% confidence interval 0.53-0.57) and 0.74 (95% confidence interval 0.72-0.75) for prostate cancer antigen 3 and 0.88 (95% confidence interval 0.86-0.90) and 0.36 (95% confidence interval 0.34-0.38) for the Prostate Health Index. The area under the curve was 0.72 for prostate cancer antigen 3 and 0.76 for the Prostate Health Index. The combination of prostate cancer antigen 3 and the Prostate Health Index had a higher area under the curve (0.79) and diagnostic odds ratio (5.83) than the use of Prostate Health Index (area under the curve 0.75, diagnostic odds ratio 4.69) or prostate cancer antigen 3 (area under the curve 0.77, diagnostic odds ratio 4.84) alone. For clinically significant prostate cancer detection, the pooled sensitivity and specificity were 0.80 (95% confidence interval 0.76-0.84) and 0.53 (95% confidence interval 0.50-0.55), respectively, for prostate cancer antigen 3, and 0.77 (95% confidence interval 0.71-0.82) and 0.64 (95% confidence interval 0.61-0.67), respectively, for the Prostate Health Index. The area under the curve was 0.71 for prostate cancer antigen 3 and 0.77 for the Prostate Health Index. Conclusion Both the Prostate Health Index and prostate cancer antigen 3 showed acceptable and similar results for the detection of overall and clinically significant prostate cancer at first biopsy. A combination of these two diagnostic tests may be more helpful than the use of either test alone in prostate cancer management.
引用
收藏
页码:315 / 325
页数:11
相关论文
共 32 条
[1]   Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer [J].
Auprich, Marco ;
Bjartell, Anders ;
Chun, Felix K. -H. ;
de la Taille, Alexandre ;
Freedland, Stephen J. ;
Haese, Alexander ;
Schalken, Jack ;
Stenzl, Arnulf ;
Tombal, Bertrand ;
van der Poel, Henk .
EUROPEAN UROLOGY, 2011, 60 (05) :1045-1054
[2]   The role of a single PCA3 test before a first negative prostate biopsy: 5-year follow-up [J].
Bernardeau, S. ;
Charles, T. ;
Fromont-Hankard, G. ;
Irani, J. .
PROGRES EN UROLOGIE, 2017, 27 (05) :325-330
[3]   Prostate Cancer Early Detection, Version 2.2016 [J].
Carroll, Peter R. ;
Parsons, J. Kellogg ;
Andriole, Gerald ;
Bahnson, Robert R. ;
Castle, Erik P. ;
Catalona, William J. ;
Dahl, Douglas M. ;
Davis, John W. ;
Epstein, Jonathan I. ;
Etzioni, Ruth B. ;
Farrington, Thomas ;
Hemstreet, George P., III ;
Kawachi, Mark H. ;
Kim, Simon ;
Lange, Paul H. ;
Loughlin, Kevin R. ;
Lowrance, William ;
Maroni, Paul ;
Mohler, James ;
Morgan, Todd M. ;
Moses, Kelvin A. ;
Nadler, Robert B. ;
Poch, Michael ;
Scales, Chuck ;
Shaneyfelt, Terrence M. ;
Smaldone, Marc C. ;
Sonn, Geoffrey ;
Sprenkle, Preston ;
Vickers, Andrew J. ;
Wake, Robert ;
Shead, Dorothy A. ;
Freedman-Cass, Deborah A. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (05) :509-519
[4]   Immunohistochemical staining of prostate cancer with monoclonal antibodies to the precursor of prostate-specific antigen [J].
Chan, TY ;
Mikolajczyk, SD ;
Lecksell, K ;
Shue, MJ ;
Rittenhouse, HG ;
Partin, AW ;
Epstein, JI .
UROLOGY, 2003, 62 (01) :177-181
[5]   Urinary PCA3 as a Predictor of Prostate Cancer in a Cohort of 3,073 Men Undergoing Initial Prostate Biopsy [J].
Chevli, K. Kent ;
Duff, Michael ;
Walter, Peter ;
Yu, Changhong ;
Capuder, Brian ;
Elshafei, Ahmed ;
Malczewski, Stephanie ;
Kattan, Michael W. ;
Jones, J. Stephen .
JOURNAL OF UROLOGY, 2014, 191 (06) :1743-1748
[6]   Diagnostic Performance of PCA3 to Detect Prostate Cancer in Men with Increased Prostate Specific Antigen: A Prospective Study of 1,962 Cases [J].
Crawford, E. David ;
Rove, Kyle O. ;
Trabulsi, Edouard J. ;
Qian, Junqi ;
Drewnowska, Krystyna P. ;
Kaminetsky, Jed C. ;
Huisman, Thomas K. ;
Bilowus, Mark L. ;
Freedman, Sheldon J. ;
Glover, W. Lloyd, Jr. ;
Bostwick, David G. .
JOURNAL OF UROLOGY, 2012, 188 (05) :1726-1731
[7]   Evaluation of prostate cancer antigen 3 for detecting prostate cancer: a systematic review and meta-analysis [J].
Cui, Yong ;
Cao, Wenzhou ;
Li, Quan ;
Shen, Hua ;
Liu, Chao ;
Deng, Junpeng ;
Xu, Jiangfeng ;
Shao, Qiang .
SCIENTIFIC REPORTS, 2016, 6
[8]   Clinical Evaluation of the PCA3 Assay in Guiding Initial Biopsy Decisions [J].
de la Taille, Alexandre ;
Irani, Jacques ;
Graefen, Markus ;
Chun, Felix ;
de Reijke, Theo ;
Kil, Paul ;
Gontero, Paolo ;
Mottaz, Alain ;
Haese, Alexander .
JOURNAL OF UROLOGY, 2011, 185 (06) :2119-2125
[9]   Prostate Health Index outperforms other PSA derivatives in predicting a positive biopsy in men with tPSA <10 ng/mL: Largest prospective cohort in Taiwan [J].
Fan, Yu-Hua ;
Pan, Po-Hsun ;
Lin, Tzu-Ping ;
Huang, Tzu-Hao ;
Wei, Tzu-Chun ;
Huang, I-Shen ;
Lin, Chih-Chieh ;
Huang, Eric Y. H. ;
Chung, Hsiao-Jen ;
Huang, William J. S. .
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (10) :772-777
[10]   Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers [J].
Filella, Xavier ;
Foj, Laura .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (11)